Review: taking Claritin and Mucinex together


Summary

Drug interactions are reported among people who take Claritin and Mucinex together. This review analyzes the effectiveness and drug interactions between Claritin and Mucinex. It is created by eHealthMe based on reports of 1,104 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 38,013 users)

Mucinex

Mucinex has active ingredients of guaifenesin. It is often used in cough. (latest outcomes from Mucinex 9,449 users)

On Sep, 18, 2016

1,104 people who take Claritin, Mucinex are studied.


Number of reports submitted per year:

Claritin and Mucinex drug interactions.

Drug effectiveness over time:

Claritin:
  • < 1 month: 27.0% - (3 of 11 people)
  • 1 - 6 months: 0.0% - (0 of 6 people)
  • 6 - 12 months: 0.0% - (0 of 4 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex:
  • < 1 month: 35.0% - (5 of 14 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 33.0% - (1 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Claritin:
  • female: 21.0% - (4 of 19 people)
  • male: 36.0% - (4 of 11 people)
Mucinex:
  • female: 55.0% - (10 of 18 people)
  • male: 9.0% - (1 of 11 people)

Drug effectiveness by age:

Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 22.0% - (2 of 9 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 14.0% - (1 of 7 people)
  • 60+: 57.0% - (4 of 7 people)
Mucinex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 20.0% - (2 of 10 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 42.0% - (3 of 7 people)
  • 60+: 57.0% - (4 of 7 people)

Most common drug interactions over time *:

< 1 month:
  • headache
  • dizziness
  • drug ineffective
  • nausea
  • pruritus generalised
  • abdominal pain
  • anaphylactic reaction
  • atelectasis
  • back pain
  • cardiopulmonary failure
1 - 6 months:
  • fatigue
  • blood alkaline phosphatase increased
  • bronchitis
  • chest pain
  • cleft palate
  • depression
  • dizziness
  • dyspnoea
  • foetal exposure during pregnancy
  • gastrooesophageal reflux disease
6 - 12 months:
  • fatigue
  • gastrooesophageal reflux disease
  • pneumonia
  • productive cough
  • pyrexia
  • renal failure chronic
  • abdominal pain
  • acute sinusitis
  • alopecia
  • anaemia
1 - 2 years:
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic nephropathy
  • glucose tolerance impaired
  • hypoglycaemia
  • type 2 diabetes mellitus
2 - 5 years:
  • abdominal pain
  • acute sinusitis
  • alopecia
  • anaemia
  • arthropathy
  • asthma
  • blood alkaline phosphatase increased
  • blood creatine phosphokinase abnormal
  • breast mass
  • bronchitis
5 - 10 years:
  • arthralgia
  • biopsy breast abnormal
  • breast cancer
  • breast necrosis
  • dyspnoea
  • fibrocystic breast disease
  • mammogram abnormal
  • musculoskeletal pain
  • nasal septum deviation
  • osteoporosis
10+ years:
  • anxiety
  • deep vein thrombosis
  • emotional distress
  • general physical health deterioration
  • injury
  • pain
  • pulmonary embolism
  • asthma
  • atrial fibrillation
  • fuchs' syndrome
not specified:
  • pain
  • dyspnoea
  • cough
  • nausea
  • dizziness
  • fatigue
  • diarrhoea
  • back pain
  • headache
  • asthenia

Most common drug interactions by gender *:

female:
  • pain
  • dyspnoea
  • nausea
  • dizziness
  • cough
  • diarrhoea
  • sinusitis
  • pancreatitis
  • fall
  • headache
male:
  • dyspnoea
  • pain
  • cough
  • fatigue
  • nausea
  • asthenia
  • back pain
  • pneumonia
  • chronic obstructive pulmonary disease
  • rash

Most common drug interactions by age *:

0-1:
  • accidental overdose
  • cleft palate
  • foetal exposure during pregnancy
  • gingival cyst
  • hydrocele
  • otitis media chronic
  • pierre robin syndrome
2-9:
  • cough
  • haemorrhage
  • pneumonia
  • rash
10-19:
  • hallucination, auditory
  • suicidal ideation
  • anxiety
  • depression aggravated
  • drug effect increased
  • abdominal pain lower
  • abortion spontaneous
  • anhedonia
  • calculus urinary
  • cataract
20-29:
  • anxiety
  • emotional distress
  • injury
  • pain
  • pulmonary embolism
  • deep vein thrombosis
  • general physical health deterioration
  • anhedonia
  • abdominal pain upper
  • chest pain
30-39:
  • dizziness
  • pulmonary embolism
  • anxiety
  • loss of consciousness
  • pain
  • chest pain
  • injury
  • malaise
  • nausea
  • visual impairment
40-49:
  • pancreatitis
  • cough
  • fatigue
  • arthralgia
  • drug ineffective
  • dyspnoea
  • bursitis
  • pain
  • abdominal pain
  • asthma
50-59:
  • pain
  • sinusitis
  • nausea
  • depression
  • oedema peripheral
  • headache
  • spinal osteoarthritis
  • rotator cuff syndrome
  • rash
  • fall
60+:
  • dyspnoea
  • pain
  • cough
  • asthenia
  • pneumonia
  • dizziness
  • diarrhoea
  • fall
  • constipation
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Claritin and Mucinex?

Can you answer these questions?

More questions for: Claritin, Mucinex

You may be interested in these reviews

More reviews for: Claritin, Mucinex

On eHealthMe, Claritin (loratadine) is often used to treat hypersensitivity. Mucinex (guaifenesin) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.